BIOMAT Database Logo BIOMAT Database Logo

[ICRF 159--a cytostatic substance]. 1978

K Hellmann, and K Rieche

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011929 Razoxane An antimitotic agent with immunosuppressive properties. ICRF-159,ICRF-186,NSC-129943,Razoxane Mesylate, (R)-Isomer,Razoxane, (R)-Isomer,Razoxin,ICRF 159,ICRF 186,ICRF159,ICRF186,NSC 129943,NSC129943
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

K Hellmann, and K Rieche
Cumulative cytostatic effect of ICRF 159.
February 1974, Nature,
K Hellmann, and K Rieche
Mode of action of the cytostatic agent "ICRF 159".
May 1970, Nature,
K Hellmann, and K Rieche
Editoral: ICRF 159.
March 1974, Lancet (London, England),
K Hellmann, and K Rieche
Letter: ICRF 159.
May 1974, Lancet (London, England),
K Hellmann, and K Rieche
Letter: ICRF 159.
March 1974, Lancet (London, England),
K Hellmann, and K Rieche
Razoxane (ICRF 159) in psoriasis.
December 1976, Lancet (London, England),
K Hellmann, and K Rieche
in vitro effects of ICRF 159.
July 1973, British journal of cancer,
K Hellmann, and K Rieche
ICRF-159: current status and clinical prospects.
November 1977, European journal of cancer,
K Hellmann, and K Rieche
Bioassay of ICRF-159 for possible carcinogenicity.
January 1978, National Cancer Institute carcinogenesis technical report series,
K Hellmann, and K Rieche
Effect of ICRF 159 on immune responses.
March 1972, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!